The findings were presented at the 17th Clinical Trials on Alzheimer's Disease (CTAD) conference. Metabolic and vascular ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

Diagnosis of Alzheimer's disease (AD) is currently largely based on the presence of biomarkers. This may lead to a ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

The active ingredient in Ozempic was associated with a 40% to 70% lower risk of a first-time Alzheimer’s diagnosis in ...

Today, Prof. Howard Feldman presented revised diagnostic criteria for Alzheimer's disease at the Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid on behalf of the International ...

Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.

The Northeastern New York chapter of the Alzheimer's Association held it's 2024 Walk to End Alzheimer's at the Clark Sports ...